Terms: = Skin cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
130 results:
1. Genetic predisposition to childhood obesity does not influence the risk of developing skin cancer in adulthood.
Keatley J; Law MH; Seviiri M; Olsen CM; Pandeya N; Ong JS; MacGregor S; Whiteman DC; Dusingize JC
Sci Rep; 2024 Apr; 14(1):7854. PubMed ID: 38570581
[TBL] [Abstract] [Full Text] [Related]
2. TNF and IFNγ-induced cell death requires IRF1 and ELAVL1 to promote casp8 expression.
Deng B; Wang J; Yang T; Deng Z; Yuan J; Zhang B; Zhou Z; Chen F; Fang L; Liang C; Yan B; Ai Y
J Cell Biol; 2024 Mar; 223(3):. PubMed ID: 38319288
[TBL] [Abstract] [Full Text] [Related]
3. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
Camera S; Rimini M; Rossari F; Tada T; Suda G; Shimose S; Kudo M; Yoo C; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Bergamo F; Salani F; Marseglia M; Amadeo E; Vitiello F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Iavarone M; Cabibbo G; Montes M; Foschi FG; Vivaldi C; Lonardi S; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Hiraoka A; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Foti S; Piscaglia F; Scartozzi M; Cascinu S; Casadei-Gardini A
Target Oncol; 2024 Jan; 19(1):29-39. PubMed ID: 38252195
[TBL] [Abstract] [Full Text] [Related]
4. TIGIT
Tsakmaklis A; Farowski F; Zenner R; Lesker TR; Strowig T; Schlößer H; Lehmann J; von Bergwelt-Baildon M; Mauch C; Schlaak M; Knuever J; Schweinsberg V; Heinzerling LM; Vehreschild MJGT
BMC Cancer; 2023 Nov; 23(1):1160. PubMed ID: 38017389
[TBL] [Abstract] [Full Text] [Related]
5. Sézary syndrome originates from heavily mutated hematopoietic progenitors.
Harro CM; Sprenger KB; Chaurio RA; Powers JJ; Innamarato P; Anadon CM; Zhang Y; Biswas S; Mandal G; Mine JA; Cortina C; Nagy MZ; Martin AL; Handley KF; Borjas GJ; Chen PL; Pinilla-Ibarz J; Sokol L; Yu X; Conejo-Garcia JR
Blood Adv; 2023 Sep; 7(18):5586-5602. PubMed ID: 37531660
[TBL] [Abstract] [Full Text] [Related]
6. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal cancer Group.
Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
[TBL] [Abstract] [Full Text] [Related]
7. Herniarin-loaded solid lipid nanoparticles: promising molecular mechanism and therapeutic potential against pancreatic cancer line.
Delkhah AMD; Karimi E; Farivar S
Mol Biol Rep; 2023 Aug; 50(8):6469-6479. PubMed ID: 37326747
[TBL] [Abstract] [Full Text] [Related]
8. The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial.
Waterhouse M; Ebeling PR; McLeod DSA; English D; Romero BD; Baxter C; Armstrong BK; Hartel G; Kimlin M; O'Connell RL; van der Pols JC; Venn AJ; Webb PM; Whiteman DC; Neale RE
Lancet Diabetes Endocrinol; 2023 May; 11(5):324-332. PubMed ID: 37011645
[TBL] [Abstract] [Full Text] [Related]
9. Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related casp8/CASP3/NLRP3 genes in human metastatic melanoma cells.
da Silva GB; Manica D; da Silva AP; Marafon F; Moreno M; Bagatini MD
Chem Biol Interact; 2023 Apr; 375():110427. PubMed ID: 36863647
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab.
Jiang S; Geng S; Gao X; Liu T; Luo X; Wang N; Shi N; Dong M
Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):616-625. PubMed ID: 36809922
[No Abstract] [Full Text] [Related]
11. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.
Hong JY; Ahn J; Won S; Kim SM; Cho YA; Kim CY; Sung JY; Yu DA; Lee YW; Choe YB
Sci Rep; 2022 Nov; 12(1):20690. PubMed ID: 36450739
[TBL] [Abstract] [Full Text] [Related]
12. PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis.
He R; Zhao X; Liu J; Zhou Y; Zhang X; Cheng F
Medicine (Baltimore); 2022 Oct; 101(41):e30561. PubMed ID: 36254050
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
Lin EP; Hsu CY; Berry L; Bunn P; Shyr Y
JAMA Netw Open; 2022 Aug; 5(8):e2227211. PubMed ID: 35976648
[TBL] [Abstract] [Full Text] [Related]
14. The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis.
Cui Y; Guo Y
Int J Clin Pharm; 2022 Aug; 44(4):843-851. PubMed ID: 35750983
[TBL] [Abstract] [Full Text] [Related]
15. Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases.
Zensen S; Opitz MK; Ludwig JM; Haubold J; Richly H; Siveke JT; Theysohn JM; Forsting M; Bos D; Schaarschmidt BM
Cardiovasc Intervent Radiol; 2022 Jun; 45(6):841-845. PubMed ID: 35437708
[TBL] [Abstract] [Full Text] [Related]
16. Defining novel causal SNPs and linked phenotypes at melanoma-associated loci.
Castaneda-Garcia C; Iyer V; Nsengimana J; Trower A; Droop A; Brown KM; Choi J; Zhang T; Harland M; Newton-Bishop JA; Bishop DT; Adams DJ; Iles MM; Robles-Espinoza CD
Hum Mol Genet; 2022 Aug; 31(17):2845-2856. PubMed ID: 35357426
[TBL] [Abstract] [Full Text] [Related]
17. Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.
Schuler M; Zimmer L; Kim KB; Sosman JA; Ascierto PA; Postow MA; De Vos FYFL; van Herpen CML; Carlino MS; Johnson DB; Berking C; Reddy MB; Harney AS; Berlin JD; Amaria RN
Clin Cancer Res; 2022 Jul; 28(14):3002-3010. PubMed ID: 35294522
[TBL] [Abstract] [Full Text] [Related]
18. Excision Margin and Survival in Patients with High-Risk, Primary Cutaneous Melanoma: A Retrospective Study Based on Surveillance Epidemiology and End Result (SEER) Database.
Xu MN; Rao Q
Dermatology; 2022; 238(3):534-541. PubMed ID: 34818654
[TBL] [Abstract] [Full Text] [Related]
19. Interpretable Diagnosis for Whole-Slide Melanoma Histology Images Using Convolutional Neural Network.
Xie P; Zuo K; Liu J; Chen M; Zhao S; Kang W; Li F
J Healthc Eng; 2021; 2021():8396438. PubMed ID: 34760142
[TBL] [Abstract] [Full Text] [Related]
20. Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas.
Güvenç C; Antoranz A; Szumera-Ciećkiewicz A; Teterycz PP; Rutkowski PR; Rawson RV; Scolyer RA; Thompson JF; Newton-Bishop J; Stas M; Boecxstaens V; Bechter O; Vercauteren J; Garmyn M; van den Oord J; Bosisio FM
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638912
[TBL] [Abstract] [Full Text] [Related]
[Next]
